Ohh-Medical

Home Medical Device for Improving Erectile Function and Treating Erectile Dysfunction

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in February 2017 by Daniel Lischinsky, Ohh-Medical operates with 1–10 employees. The company has secured funding across one round from Arbelon Holdings Ltd. In June 2024, Ohh-Med Medical unveiled its VerticaPlus device, designed for the treatment of erectile dysfunction.

Business overview

Ohh-Medical is a medtech company specializing in innovative medical solutions for men's health. The company develops, manufactures, and markets patented medical devices to address urological conditions, including erectile dysfunction (ED). Its flagship product, Vertica, is a non-invasive, prescription-free, and side-effect-free home-use device that utilizes medical-grade radiofrequency technology to restore natural erectile mechanisms by improving collagen quality in penile tissues. Ohh-Medical targets both consumer and professional healthcare markets, operating within the Health Tech & Life Sciences sector.

Strategic signal

In June 2024, Ohh-Med Medical unveiled its VerticaPlus device for erectile dysfunction. This product launch indicates the company's continued innovation and expansion within the men's health market, signaling a strategic focus on enhancing its product portfolio and addressing a significant medical need with advanced, non-invasive solutions.

Log in to access full profile

Company Intelligence Q&A

What is Ohh-Medical's core product?
Ohh-Medical's core product is Vertica, a non-invasive, home-use medical device designed to improve erectile function and treat erectile dysfunction using medical-grade radiofrequency technology.
When was Ohh-Medical founded?
Ohh-Medical was founded in February 2017.
Has Ohh-Medical received regulatory approvals for its products?
Yes, Vertica received European CE MDR approval to market in Europe in 2023, and in 2021, the company received approval to market Vertica in Israel.
What was a significant product development for Ohh-Medical in 2024?
In June 2024, Ohh-Med Medical unveiled its VerticaPlus device, an advancement aimed at treating erectile dysfunction.
What was a key clinical milestone for Ohh-Medical?
A pilot clinical study conducted at the Neuro-Urology unit, Rambam Healthcare Campus, demonstrated an 85% success rate for Vertica, with 25 out of 28 patients experiencing significant improvement in erectile function.
Log in to access full profile